It describes structured follow-up at 2 to 4 weeks after initiation, then every 4 to 12 weeks to assess tolerability, weight-loss trajectory, and adherence
Researchers then evaluated how BMI changes related to the risk of developing osteoarthritis, chronic kidney disease (CKD), obstructive sleep apnea (OSA), and heart failure
In humans, we have recently shown that the GLP-1 RA dulaglutide tends to reduce fluid intake and lowers 24-hour urinary output in healthy volunteers (24)
Keep in mind that we need to be careful of anyone taking opiates with LDN we recommend a full drug therapy review before starting LDN
As GLP-1 receptor agonists, they play a crucial role in regulating blood glucose levels and controlling appetite, aligning with our holistic approach to patient health